SCM Lifescience Co., Ltd. (KOSDAQ:298060)

SCM Lifescience Statistics

Total Valuation

SCM Lifescience has a market cap or net worth of KRW 47.76 billion. The enterprise value is 38.86 billion.

Market Cap	47.76B
Enterprise Value	38.86B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SCM Lifescience has 39.47 million shares outstanding. The number of shares has increased by 11.16% in one year.

Current Share Class	39.47M
Shares Outstanding	39.47M
Shares Change (YoY)	+11.16%
Shares Change (QoQ)	-86.97%
Owned by Insiders (%)	5.49%
Owned by Institutions (%)	n/a
Float	7.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	30.95
PB Ratio	1.96
P/TBV Ratio	2.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.72
EV / Sales	25.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.35

Financial Position

The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.11.

Current Ratio	6.61
Quick Ratio	6.34
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-26.58

Financial Efficiency

Return on equity (ROE) is -41.87% and return on invested capital (ROIC) is -22.35%.

Return on Equity (ROE)	-41.87%
Return on Assets (ROA)	-21.08%
Return on Invested Capital (ROIC)	-22.35%
Return on Capital Employed (ROCE)	-31.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	2.38

Taxes

Income Tax	-661.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.69% in the last 52 weeks. The beta is 1.09, so SCM Lifescience's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-40.69%
50-Day Moving Average	1,057.70
200-Day Moving Average	1,244.62
Relative Strength Index (RSI)	60.89
Average Volume (20 Days)	371,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCM Lifescience had revenue of KRW 1.54 billion and -8.24 billion in losses. Loss per share was -362.75.

Revenue	1.54B
Gross Profit	518.50M
Operating Income	-8.25B
Pretax Income	-8.90B
Net Income	-8.24B
EBITDA	-7.35B
EBIT	-8.25B
Loss Per Share	-362.75

Balance Sheet

The company has 11.56 billion in cash and 2.66 billion in debt, giving a net cash position of 8.90 billion or 225.45 per share.

Cash & Cash Equivalents	11.56B
Total Debt	2.66B
Net Cash	8.90B
Net Cash Per Share	225.45
Equity (Book Value)	24.38B
Book Value Per Share	744.27
Working Capital	10.89B

Cash Flow

In the last 12 months, operating cash flow was -8.39 billion and capital expenditures -8.16 billion, giving a free cash flow of -16.55 billion.

Operating Cash Flow	-8.39B
Capital Expenditures	-8.16B
Free Cash Flow	-16.55B
FCF Per Share	-419.38

Margins

Gross Margin	33.60%
Operating Margin	-534.51%
Pretax Margin	-576.74%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SCM Lifescience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.16%
Shareholder Yield	n/a
Earnings Yield	-17.25%
FCF Yield	-34.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 15, 2023
Split Type	Forward
Split Ratio	1.2

Scores

SCM Lifescience has an Altman Z-Score of -3.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.97
Piotroski F-Score	2